completed Budget Impact Analysis of Atorvastatin for Primary Prevention of Cardiovascular Disease in Type 2 Diabetes Mellitus
본문
PERIOD: 2019.11.19-2024.12.31
SPONSOR: Global Pharmaceutical Company based in Korea
RESEARCH
Pharmaceutical Economics,Big Data Analysis & Policy Lab